Studies on succinate dehydrogenase: I. Spectral properties of the purified enzyme and formation of enzyme-competitive inhibitor complexes

https://doi.org/10.1016/0926-6569(64)90182-8Get rights and content

Abstract

  • 1.

    1. Succinate dehydrogenase (succinate: (acceptor) oxidoreductase, EC 1.3.99.1) reacts immediately with competitive inhibitors to form spectrally detectable enzyme-inhibitor complexes, which are converted to succinate-reduced enzyme on the subsequent addition of succinate.

  • 2.

    2. The enzyme-inhibitor complexes formed with malonate, fumarate, maleate and methylene succinate differ from that with oxaloacetate in spectral characteristics, the latter showing a wide, diffuse band from 500 to 750 mμ.

  • 3.

    3. Pyrophosphate, a strong competitive inhibitor of succinate dehydrogenase, but which is not in any obvious way structurally related to succinate, has no effect on the spectrum.

  • 4.

    4. Dissociation constants of the enzyme-inhibitor complexes determined by spectral titration are in good agreement with kinetically determined inhibitor constants.

  • 5.

    5. The changes in spectrum associated with the formation of the enzyme-inhibitor complexes are explainable in terms of changes in polarity near the flavin prosthetic group and by the formation of charge-transfer complexes between the electron-donating inhibitor and the electron-accepting enzyme.

  • 6.

    6. The apparent incomplete reoxidation by fumarate of dithionite-reduced enzyme, reported by previous workers, can be explained by the formation of the complex between oxidized enzyme and fumarate.

References (51)

  • T.P. Singer et al.

    J. Biol. Chem.

    (1956)
  • E.B. Kearney

    J. Biol. Chem.

    (1960)
  • V. Massey et al.

    Biochim. Biophys. Acta

    (1961)
  • V. Massey et al.

    J. Biol. Chem.

    (1957)
  • A.G. Gornall et al.

    J. Biol. Chem.

    (1949)
  • E.B. Kearney et al.

    J. Biol. Chem.

    (1956)
  • T.E. King

    J. Biol. Chem.

    (1963)
  • L. Hellerman et al.

    Biochem. J.

    (1960)
  • H. Beinert et al.

    Biochim. Biophys. Res. Commun.

    (1960)
  • T.E. King et al.

    Biochim. Biophys. Res. Commun.

    (1961)
  • D.V. Dervartanian et al.

    Biochim. Biophys. Acta

    (1963)
  • E.B. Kearney

    J. Biol. Chem.

    (1957)
  • T. Kimura et al.

    Biochim. Biophys. Res. Commun.

    (1963)
  • K. Yagi et al.

    Biochim. Biophys. Acta

    (1963)
  • C. Veeger et al.

    Biochim. Biophys. Acta

    (1962)
  • T.E. King

    J. Biol. Chem.

    (1963)
  • V. Massey

    Biochim. Biophys. Acta

    (1958)
  • R. Aasa et al.

    Biochim. Biophys. Acta

    (1963)
  • J.S. Rieske et al.

    Biochim. Biophys. Res. Commun.

    (1964)
  • T.Y. Wang et al.

    Sci. Sinica Peking

    (1956)
  • T.Y. Wang et al.

    Sci. Sinica Peking

    (1958)
  • D. Keilin et al.
  • D.V. Dervartanian et al.

    Biochem. J.

    (1962)
  • C. Veeger
  • D. Keilin et al.

    Biochem. J.

    (1947)
  • Cited by (94)

    • Nutrient-use efficiency

      2023, Marschner's Mineral Nutrition of Plants
    • Succinate accumulation contributes to oxidative stress and iron accumulation in pentylenetetrazol-induced epileptogenesis and kainic acid-induced seizure

      2021, Neurochemistry International
      Citation Excerpt :

      In our previous study, we found that inhibition of MAS or PNC pathway resulted in reduced succinate accumulation (Zhang et al., 2020). DM is the cell permeable molecule dimethyl malonate, which is rapidly hydrolyzed within the cell to generate malonate, a potent competitive inhibitor of succinate oxidation by SDH (Dervartanian et al., 1964). The accumulation of succinate, via fumarate production and reverse catalysis of SDH, is a universal metabolic signature of ischemia in vivo (Chouchani et al., 2014).

    • The iron–sulfur protein subunit of succinate dehydrogenase is critical in driving mitochondrial reactive oxygen species generation in Apostichopus japonicus

      2020, Fish and Shellfish Immunology
      Citation Excerpt :

      Our finding that succinate oxidation is an important regulator of inflammatory signaling presents a number of novel therapeutic opportunities in A. japonicus. As a potent competitive inhibitor of succinate oxidation, dimethyl malonate (DMM) may be useful in treating inflammatory diseases in which IL-1β has been linked to their pathogenesis [57,58]. SDH inhibition with DMM has shown efficacy in a mouse model of acute LPS-induced sepsis and previously in mouse models of E. coli infection and I/R injury [7,23].

    • Inhibiting Succinate Dehydrogenase by Dimethyl Malonate Alleviates Brain Damage in a Rat Model of Cardiac Arrest

      2018, Neuroscience
      Citation Excerpt :

      The body temperature of rats was maintained at 36.5 °C to 37.5 °C using a heating lamp. DMM (Sigma–Aldrich, USA) is able to cross the blood–brain barrier and hydrolyze to malonate, which is a competitive inhibitor of SDH (Dervartanian and Veeger, 1964). DMM was diluted to 10% (w/v) with normal saline.

    View all citing articles on Scopus

    Present address: Department of Biochemistry, Agricultural University, Wageningen, the Netherlands.

    View full text